Intrinsiqq
Aehr Test Systems logo

Aehr Test Systems (AEHR) Insider Trading

Last 12 months

Insiders sold $60.9M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. President and CEO Gayn Erickson sold $10.8M on Apr 10, 28% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2024.

Net open-market
−$60.9M
0 buys · 48 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 13
executives and directors
Last open-market buy
Aug 2024
Aug 2, 2024

Get an email when AEHR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 14 – 17No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 5,994 at avg $141.34
    $847k
    3.1% of stake
  • Aug 14No plan
    Howard T Slayen
    Director · sold 5,700 at $133.03
    $758k
    3.9% of stake
  • Aug 14No plan
    Rhea J Posedel
    Director · sold 5,973 at $140.00
    $836k
    1.4% of stake
  • Aug 13No plan
    Alberto Salamone
    EVP, PPBI BUSINESS · sold 9,672 at avg $127.72
    $1.24M
    19% of stake
  • Aug 12No plan
    Gayn Erickson
    President and CEO · sold 40,000 at avg $130.85
    $5.23M
    10% of stake
  • Aug 12No plan
    Rhea J Posedel
    Director · sold 8,413 at $130.00
    $1.09M
    1.9% of stake
  • Aug 12No plan
    Geoffrey Gates Scott
    Director · sold 20,000 at $131.51
    $2.63M
    19% of stake
  • Aug 12No plan
    Adil Engineer
    Chief Operating Officer · sold 15,000 at avg $131.03
    $1.97M
    24% of stake
  • Aug 12No plan
    Laura Oliphant
    Director · sold 1,717 at $133.00
    $228k
    9.6% of stake
  • Aug 10No plan
    Alistair N Sporck
    VP Contactor Business Unit · sold 1,000 at $108.49
    $108k
    3.5% of stake
  • Aug 4No plan
    Alistair N Sporck
    VP Contactor Business Unit · sold 2,000 at avg $100.96
    $202k
    6.5% of stake
  • Aug 4No plan
    Howard T Slayen
    Director · sold 20,000 at $108.30
    $2.17M
    12% of stake
  • Jul 16No plan
    Geoffrey Gates Scott
    Director · sold 20,000 at $82.13
    $1.64M
    15% of stake
  • May 14No plan
    Chris Siu
    CFO · sold 2,070 at avg $107.06
    $222k
    2.7% of stake
  • May 13No plan
    Howard T Slayen
    Director · sold 6,819 at $104.73
    $714k
    3.9% of stake
  • Apr 22No plan
    Rhea J Posedel
    Director · sold 17,719 at avg $99.83
    $1.77M
    3.9% of stake
  • Apr 22No plan
    Alistair N Sporck
    VP Contactor Business Unit · sold 2,000 at $93.50
    $187k
    7.3% of stake
  • Apr 20 – 21No plan
    Alberto Salamone
    EVP, PPBI BUSINESS · sold 30,000 at avg $92.07
    $2.76M
    38% of stake
  • Apr 21No plan
    Geoffrey Gates Scott
    Director · sold 60,000 at avg $94.33
    $5.66M
    28% of stake
  • Apr 21No plan
    Rhea J Posedel
    Director · sold 8,787 at $96.02
    $844k
    1.9% of stake
  • Apr 21No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 6,486 at $94.09
    $610k
    4.1% of stake
  • Apr 20No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 5,000 at $90.00
    $450k
    3.3% of stake
  • Apr 20No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 2,431 at $90.00
    $219k
    1.5% of stake
  • Apr 20No plan
    Rhea J Posedel
    Director · sold 7,500 at $88.09
    $661k
    1.6% of stake
  • Apr 17No plan
    Rhea J Posedel
    Director · sold 7,500 at $82.00
    $615k
    1.6% of stake
  • Apr 17No plan
    Howard T Slayen
    Director · sold 25,000 at $85.00
    $2.13M
    12% of stake
  • Apr 16No plan
    Fariba Danesh
    Director · sold 8,000 at $82.63
    $661k
    38% of stake
  • Apr 16No plan
    Laura Oliphant
    Director · sold 1,716 at $81.54
    $140k
    9.3% of stake
  • Apr 16No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 5,000 at $86.88
    $434k
    3.0% of stake
  • Apr 16No plan
    Alistair N Sporck
    VP Contactor Business Unit · sold 2,000 at $81.88
    $164k
    6.7% of stake
  • Apr 16No plan
    Laura Oliphant
    Director · sold 4,665 at $85.59
    $399k
    20% of stake
  • Apr 16No plan
    Rhea J Posedel
    Director · sold 15,000 at $80.72
    $1.21M
    3.0% of stake
  • Apr 13 – 15No plan
    Didier Wimmers
    Executive VP of R&D · sold 5,400 at avg $71.43
    $386k
    34% of stake
  • Apr 14No plan
    Donald P. Richmond II
    CTO · sold 17,011 at $73.18
    $1.24M
    8.6% of stake
  • Apr 10 – 13No plan
    Fariba Danesh
    Director · sold 10,500 at avg $71.01
    $746k
    44% of stake
  • Apr 10No plan
    Gayn Erickson
    President and CEO · sold 152,824 at avg $70.58
    $10.8M
    28% of stake
  • Apr 10No plan
    Alistair N Sporck
    VP Contactor Business Unit · sold 2,000 at $67.37
    $135k
    6.3% of stake
  • Apr 10No plan
    Vernon Rogers
    Exec VP of Sales & Mktg. · sold 10,888 at $70.00
    $762k
    6.1% of stake
  • Apr 9No plan
    Geoffrey Gates Scott
    Director · sold 40,000 at avg $68.02
    $2.72M
    16% of stake
  • Apr 9No plan
    Adil Engineer
    Chief Operating Officer · sold 3,728 at avg $66.30
    $247k
    8.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AEHR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Instruments For Meas & Testing of Electricity & Elec Signals

Spot a number that looks wrong? Check it in AEHR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AEHR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.